Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP1941 vs Acarbose in Asian Subjects with Type 2 Diabetes
NCT01514838Phase 3Terminated
- Sponsor
- Astellas Pharma
- Start
- Apr 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ipragliflozin in type 2 diabetes mellitus (T2DM), sponsored by Astellas Pharma. Started Apr 2012; status: terminated.
02
Drugs
ipragliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01514838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01514838.